An in-depth look to VERONA PHARMA SP.ADR 8 operating, investing, and financing activities

I9SA free cash flow for Q3 24 is -56.64 M EUR. For 2023, I9SA free cash flow was -45.68 M EUR and operating cash flow was -45.68 M EUR.